It suggested that obesity was related to the risk of breast tumors with lower aggressiveness such as ER+, PR+, HER2–, Ki67low, Bcl-2+, and p53– tumors in postmenopausal women. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.